Related Experiment Video
Updated: Jul 16, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
[Intestinal Flora Dysregulation and Lung Cancer: Mechanism Analysis and Clinical Application]
Liangyuan Chen1, Yiqing Xie1, Chong Li1
1Department of Respiratory Medicine, Changzhou First People's Hospital/Nanjing Medical University, Changzhou 213000, China.
Abstract:
Lung cancer is the deadliest form of cancer globally, with millions of new cases diagnosed each year. Although rapid advancements in surgical techniques, targeted therapies, and immunotherapy have significantly improved patient outcomes, the overall 5-year survival rate remains disappointingly low. Recent studies have highlighted the vital role of gut microbiota in maintaining host health and its close association with the onset and progression of lung cancer through various mechanisms. This article provides a systematic analysis of the role of gut microbiota in lung cancer, focusing on its immunomodulatory and metabolic functions, as well as its potential applications in treatment, while also exploring its prospects for clinical use. .
Related Concept Videos
Microbiota of the Respiratory Tract
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics

